Escape of SARS-CoV-2 variants KP1.1, LB.1 and KP3.3 from approved monoclonal antibodies
Delphine Planas, Isabelle Staropoli, Cyril Planchais, Emilie Yab, Banujaa Jeyarajah, Yannis Rahou, Matthieu Prot, Florence Guivel‐Benhassine, Frederic Lemoine, Vincent Enouf, Etienne Simon‐Lorière, Hugo Mouquet, Marie‐Anne Rameix‐Welti, Olivier Schwartz
The paper evaluates the neutralization activity of two new monoclonal antibodies against emerging SARS-CoV-2 variants and finds reduced efficacy against some sublineages.
Pathogens and Immunity · Sep 30, 2024Peer-reviewedImmunology